Novocell, Inc.
Biotech Specialty Pharma
3550 General Atomics Court 3550 General Atomics Court, Building 2-503
San Diego, CA 92121 USA
phone: (858) 455-3708
fax: (858) 455-3962
Symbol private
Exchange
Founded 0
Employees
www.novocell.com
Research Sector Biotech Specialty Pharma
Summary Description
Cellular encapsulation and islet cell transplantation for the treatment of diabetes.
Management
Alan J. Lewis, Ph.D., President, Chief Executive Officer, and Director; E. Edward Baetge, Ph.D., Vice President and Chief Scientific Officer; Allan Robins, Ph.D., Vice President and Chief Technical Officer; George Albrecht, Vice President of Quality and Regulatory Affairs; Melissa Carpenter, Ph.D., Vice President of Research and Development; Xiaojie Yu, Ph.D., Senior Director of Biomaterials Science
Ownership
Financials


* numbers in thousands

 
Keywords
insulin, Diabetes, blood sugar, diabetic, metabolic, insulin, cellular encapsulation, cell culture, inslet cell transplantation

Comment | Printable Version | Aug. 08, 2007
If you work for Novocell, Inc. and want to update this profile, click here


Description
Novocell develops cellular encapsulation and islet cell transplantation for the treatment of diabetes.
Technology / Differentiation
The company's cellular encapsulation and cell culture technology may lead to an alternative to life-long insulin injection therapy for millions of diabetics.


2008-11-17-302